Transgene expression from helper-dependent adenoviral (HD-Ad) vectors is effective and long lasting, but not permanent. Their use is also limited by the host response against capsid proteins that precludes successful gene expression upon readministration. In this report, we test the hypothesis that PEGylation of HD-Ad reduces its toxicity and promotes transgene expression upon readministration. PEGylation did not compromise transduction efficiency in vitro and in vivo and reduced peak serum IL-6 levels two-fold. IL-12 and TNF-a levels were reduced three- and sevenfold, respectively. Thrombocytopenia was not detected in mice treated with the PEGylated vector. Serum transaminases were not significantly elevated in mice treated with either vector. Mice immunized with 1X10E11 particles of unmodified HD-Ad expressing human alpha-1 antitrypsin (hA1AT) were rechallenged 28 days later with 8X10E10 particles of unmodified or PEG-conjugated vector expressing beta-galactosidase. Trace levels of beta-galactosidase (52.23719.2 pg/mg protein) were detected in liver homogenates of mice that received two doses of unmodified HDAd. Mice rechallenged with PEGylated HD-Ad produced significant levels of beta-galactosidase (5.170.4+-105 pg/mg protein, P<0.0001). This suggests that PEGylation of HD-Ad vectors may be appropriate for their safe and efficient use in the clinic.

PEGylated Helper-Dependent Adenoviral Vectors: Highly Efficient Vectors with an Enhanced Safety Profile / Croyle, M.; Le, H.; Linse, K.; Ming, X.; Cerullo, V.; Toietta, G.; Beaudet, A. L.; Pastore, Lucio. - In: GENE THERAPY. - ISSN 0969-7128. - STAMPA. - 12:7(2005), pp. 579-587. [10.1038/sj.gt.3302441]

PEGylated Helper-Dependent Adenoviral Vectors: Highly Efficient Vectors with an Enhanced Safety Profile

CERULLO V.;PASTORE, LUCIO
2005

Abstract

Transgene expression from helper-dependent adenoviral (HD-Ad) vectors is effective and long lasting, but not permanent. Their use is also limited by the host response against capsid proteins that precludes successful gene expression upon readministration. In this report, we test the hypothesis that PEGylation of HD-Ad reduces its toxicity and promotes transgene expression upon readministration. PEGylation did not compromise transduction efficiency in vitro and in vivo and reduced peak serum IL-6 levels two-fold. IL-12 and TNF-a levels were reduced three- and sevenfold, respectively. Thrombocytopenia was not detected in mice treated with the PEGylated vector. Serum transaminases were not significantly elevated in mice treated with either vector. Mice immunized with 1X10E11 particles of unmodified HD-Ad expressing human alpha-1 antitrypsin (hA1AT) were rechallenged 28 days later with 8X10E10 particles of unmodified or PEG-conjugated vector expressing beta-galactosidase. Trace levels of beta-galactosidase (52.23719.2 pg/mg protein) were detected in liver homogenates of mice that received two doses of unmodified HDAd. Mice rechallenged with PEGylated HD-Ad produced significant levels of beta-galactosidase (5.170.4+-105 pg/mg protein, P<0.0001). This suggests that PEGylation of HD-Ad vectors may be appropriate for their safe and efficient use in the clinic.
2005
PEGylated Helper-Dependent Adenoviral Vectors: Highly Efficient Vectors with an Enhanced Safety Profile / Croyle, M.; Le, H.; Linse, K.; Ming, X.; Cerullo, V.; Toietta, G.; Beaudet, A. L.; Pastore, Lucio. - In: GENE THERAPY. - ISSN 0969-7128. - STAMPA. - 12:7(2005), pp. 579-587. [10.1038/sj.gt.3302441]
File in questo prodotto:
File Dimensione Formato  
PEG-Lucio.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 212.51 kB
Formato Adobe PDF
212.51 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/109318
Citazioni
  • ???jsp.display-item.citation.pmc??? 48
  • Scopus 118
  • ???jsp.display-item.citation.isi??? 103
social impact